Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Punt

Showing results (1-10 of 466) with videos related to

Pageof 47
Sort By:
Onkologie|January 8, 2004
Statistical trial designs and clinical practice: are they compatible?C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?C J A Punt
Onkologie|December 11, 2002
Performing phase III clinical trials: never an easy taskC J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
New options and old dilemmas in the treatment of patients with advanced colorectal cancerC J A Punt
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2005
[Chemotherapy of patients with colorectal carcinoma]C J A Punt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Drug development in advanced esophagogastric cancer: the art of extrapolationCornelis J A Punt
The Netherlands Journal of Medicine|May 17, 2006
Treatment of liver metastases from colorectal cancerJ Tol, C J A Punt
The Lancet. Oncology|December 3, 2020
Duration of adjuvant treatment for patients with stage III colon cancerMiriam Koopman, Cornelis J A Punt
Clinical Therapeutics|April 20, 2010
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a reviewJolien Tol, Cornelis J A Punt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Capecitabine and irinotecan as first-line treatment of advanced colorectal cancerCornelis J A Punt, Miriam Koopman
Pageof 47

Showing results (1-10 of 466) with videos related to

Sort By:
Pageof 47
Onkologie|January 8, 2004
Statistical trial designs and clinical practice: are they compatible?C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?C J A Punt
Onkologie|December 11, 2002
Performing phase III clinical trials: never an easy taskC J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
New options and old dilemmas in the treatment of patients with advanced colorectal cancerC J A Punt
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2005
[Chemotherapy of patients with colorectal carcinoma]C J A Punt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Drug development in advanced esophagogastric cancer: the art of extrapolationCornelis J A Punt
The Netherlands Journal of Medicine|May 17, 2006
Treatment of liver metastases from colorectal cancerJ Tol, C J A Punt
The Lancet. Oncology|December 3, 2020
Duration of adjuvant treatment for patients with stage III colon cancerMiriam Koopman, Cornelis J A Punt
Clinical Therapeutics|April 20, 2010
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a reviewJolien Tol, Cornelis J A Punt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Capecitabine and irinotecan as first-line treatment of advanced colorectal cancerCornelis J A Punt, Miriam Koopman
Pageof 47